PL1758555T5 - Czynnik tworzący oleożel zawierający triterpen, oleożel zawierający triterpen oraz sposób wytwarzania oleożelu zawierającego triterpen - Google Patents

Czynnik tworzący oleożel zawierający triterpen, oleożel zawierający triterpen oraz sposób wytwarzania oleożelu zawierającego triterpen

Info

Publication number
PL1758555T5
PL1758555T5 PL05756084T PL05756084T PL1758555T5 PL 1758555 T5 PL1758555 T5 PL 1758555T5 PL 05756084 T PL05756084 T PL 05756084T PL 05756084 T PL05756084 T PL 05756084T PL 1758555 T5 PL1758555 T5 PL 1758555T5
Authority
PL
Poland
Prior art keywords
triterpene
oleogel
containing oleogel
forming agent
producing
Prior art date
Application number
PL05756084T
Other languages
English (en)
Polish (pl)
Other versions
PL1758555T3 (pl
Inventor
Armin Scheffler
Original Assignee
Birken Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34971468&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1758555(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Birken Ag filed Critical Birken Ag
Publication of PL1758555T3 publication Critical patent/PL1758555T3/pl
Publication of PL1758555T5 publication Critical patent/PL1758555T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/37—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with a hydroxy group on a condensed system having three rings
    • C07C35/42—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with a hydroxy group on a condensed system having three rings derived from the phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Colloid Chemistry (AREA)
  • Measuring Volume Flow (AREA)
PL05756084T 2004-06-22 2005-06-21 Czynnik tworzący oleożel zawierający triterpen, oleożel zawierający triterpen oraz sposób wytwarzania oleożelu zawierającego triterpen PL1758555T5 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004030044A DE102004030044A1 (de) 2004-06-22 2004-06-22 Triterpenhaltiger Oleogelbildner, triterpenhaltiges Oleogel und Verfahren zur Herstellung eines triterpenhaltigen Oleogels
EP05756084A EP1758555B2 (de) 2004-06-22 2005-06-21 Triterpenhaltiger oleogelbildner, triterpenhaltiges oleogel und verfahren zur herstellung eines triterpenhaltigen oleogels
PCT/EP2005/006710 WO2005123037A1 (de) 2004-06-22 2005-06-21 Triterpenhaltiger oleogelbildner, triterpenhaltiges oleogel und verfahren zur herstellung eines triterpenhaltigen oleogels

Publications (2)

Publication Number Publication Date
PL1758555T3 PL1758555T3 (pl) 2009-07-31
PL1758555T5 true PL1758555T5 (pl) 2011-12-30

Family

ID=34971468

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05756084T PL1758555T5 (pl) 2004-06-22 2005-06-21 Czynnik tworzący oleożel zawierający triterpen, oleożel zawierający triterpen oraz sposób wytwarzania oleożelu zawierającego triterpen

Country Status (31)

Country Link
US (2) US8536380B2 (en:Method)
EP (1) EP1758555B2 (en:Method)
JP (1) JP4468987B2 (en:Method)
KR (1) KR101162991B1 (en:Method)
CN (1) CN1972668B (en:Method)
AT (1) ATE423546T1 (en:Method)
AU (1) AU2005253732C1 (en:Method)
BE (1) BE2016C035I2 (en:Method)
BR (1) BRPI0512288B8 (en:Method)
CA (1) CA2571606C (en:Method)
CY (2) CY1109066T1 (en:Method)
DE (2) DE102004030044A1 (en:Method)
DK (1) DK1758555T4 (en:Method)
ES (1) ES2323082T5 (en:Method)
FR (1) FR16C1003I2 (en:Method)
HU (1) HUS1600032I1 (en:Method)
IL (1) IL180057A (en:Method)
LT (1) LTC1758555I2 (en:Method)
LU (1) LU93142I2 (en:Method)
MX (1) MXPA06015233A (en:Method)
NL (1) NL300823I2 (en:Method)
NO (2) NO336747B1 (en:Method)
NZ (1) NZ552280A (en:Method)
PL (1) PL1758555T5 (en:Method)
PT (1) PT1758555E (en:Method)
RS (1) RS50832B2 (en:Method)
RU (1) RU2430717C2 (en:Method)
SI (1) SI1758555T2 (en:Method)
UA (1) UA88308C2 (en:Method)
WO (1) WO2005123037A1 (en:Method)
ZA (1) ZA200610304B (en:Method)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2332525A1 (en) 2009-11-23 2011-06-15 Novaliq GmbH Pharmaceutical composition comprising propofol
DE102009047092A1 (de) * 2009-11-24 2011-05-26 Birken Gmbh Verwendung eines triterpenhaltigen Oleogels zur Wundheilung
EP2335675B1 (de) 2009-12-10 2015-02-18 Neubourg Skin Care GmbH & Co. KG Emulgatorfreie, Polymer-stabilisierte Schaumformulierungen
EP2363108B1 (de) 2010-03-02 2017-08-30 Neubourg Skin Care GmbH & Co. KG Schaumformulierungen enthaltend mindestens ein Triterpenoid
WO2012177825A1 (en) 2011-06-21 2012-12-27 Bvw Holding Ag Medical device comprising boswellic acid
US20190281853A1 (en) * 2016-05-12 2019-09-19 Rudjer Boskovic Institute Low molecular weight organic gelators of vegetable oil
JP2019524755A (ja) * 2016-07-18 2019-09-05 アムリット・リサーチ・リミテッド ベツリン含有油中水型泡沫及びその組成物
WO2018165505A1 (en) * 2017-03-10 2018-09-13 Kraton Polymers U.S. Llc Fusible oil gel compositions and methods of making and using same
KR102692754B1 (ko) 2017-08-31 2024-08-08 (주)아모레퍼시픽 병풀 추출물 또는 이로부터 유래한 트리테르펜을 고함량으로 포함하는 화장료 조성물 및 이의 제조 방법
JP7551496B2 (ja) 2017-10-31 2024-09-17 カリヴィル イムノセラピューティクス， インコーポレイテッド 全身送達のためのプラットフォーム腫瘍溶解性ベクター
US20200330481A1 (en) 2018-01-04 2020-10-22 Amryt Research Limited Betulin-containing birch bark extracts and their formulation
WO2020084548A1 (en) 2018-10-26 2020-04-30 Viramal Limited Mucoadhesive gel composition
EP3659583B1 (en) 2018-11-30 2023-06-07 Viramal Limited A method of preparing a gelling agent, the gelling agent obtained thereby, and the use of said gelling agent
CN109512780A (zh) * 2019-01-09 2019-03-26 河南省医药科学研究院 一种凝胶药膏及其制备方法和应用
GR1010072B (el) * 2019-05-15 2021-09-15 Αριστοτελειο Πανεπιστημιο Θεσσαλονικης - Ειδικος Λογαριασμος Κονδυλιων Ερευνας Βρωσιμα κτηνιατρικα σκευασματα ενδομαστικης προστασιας θηλαστικων και μεθοδος για την παρασκευη τους
WO2022109133A1 (en) 2020-11-19 2022-05-27 Kalivir Immunotherapeutics, Inc. Oncolytic immunotherapy by tumor micro-environment remodeling
KR20240004764A (ko) 2021-04-30 2024-01-11 칼리버 임뮤노쎄라퓨틱스, 인크. 변형된 mhc 발현을 위한 종양용해성 바이러스

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU83173A1 (fr) 1981-02-27 1981-06-05 Oreal Nouvelles compositions cosmetiques pour le traitement des cheveux et de la peau contenant une poudre resultant de la pulverisation d'au moins une plante et un agent de cohesion
JP3363161B2 (ja) 1991-06-27 2003-01-08 ポーラ化成工業株式会社 非水ゲル化粧料
US5750578A (en) 1997-02-11 1998-05-12 Regents Of The University Of Minnesota Use of betulin and analogs thereof to treat herpesvirus infection
US6403816B1 (en) * 1997-09-30 2002-06-11 Dabur Research Foundation Betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis
FR2779438B1 (fr) * 1998-06-03 2004-12-24 Jean Marc Aiache Gel stable, son procede de preparation, et compositions pharmaceutiques le comprenant
GB9908593D0 (en) 1999-04-16 1999-06-09 Quest Int Dental compositions containing boswellia extracts
DE60002581T2 (de) 1999-07-09 2004-03-25 Bsp Pharma A/S Zusammensetzung enthaltend butyrospermum parkii extrakte und die verwendung als arzneimittel oder nahrungszusatz
DE60102402T2 (de) 2000-02-10 2005-03-10 Loders Croklaan B.V. Fettmischungen mit Kristallmodifikatoren
DE10056902A1 (de) * 2000-11-16 2002-05-23 Birken Gmbh Verfahren zur Gewinnung von Triterpenen aus Pflanzen sowie deren Verwendung
DE50102055D1 (de) * 2000-03-28 2004-05-27 Birken Gmbh Emulsion enthaltend einen triterpen-haltigen pflanzenextrakt, verfahren zur herstellung der emulsion sowie zur gewinnung des pflanzenextraktes
AU2001294959A1 (en) 2000-09-29 2002-04-08 Robert M. Carlson Triterpenes having antibacterial activity
US6642217B2 (en) 2000-09-29 2003-11-04 Naturtek, Llc Triterpenes having human antifungal and antiyeast activity
JP2002138014A (ja) 2000-10-31 2002-05-14 Noevir Co Ltd 微細エマルション組成物
DE10143964A1 (de) 2001-09-07 2003-03-27 Basf Ag Emulgatorarme oder emulgatorfreie Systeme vom Typ Öl-in-Wasser mit einem Gehalt an Stabilisatoren und einem aminosubstituierten Hydroxybenzophenon
DE10156297A1 (de) * 2001-11-19 2003-05-28 Henkel Kgaa Mittel zum Schutz der Haut
JP2003335627A (ja) 2002-03-14 2003-11-25 Lion Corp 化粧料含浸シート
DE10237281A1 (de) 2002-08-14 2004-03-04 Birken Gmbh Vorrichtung zur kontinuierlichen Extraktion von Extraktstoffen aus Pflanzen
JP3779661B2 (ja) 2002-09-13 2006-05-31 花王株式会社 皮膚化粧料
KR100489701B1 (ko) * 2002-10-09 2005-05-16 주식회사 태평양 고농도의 트리터페노이드를 함유하는 미소화 리포좀 및 그제조방법
JP2005004911A (ja) 2003-06-13 2005-01-06 Ikuta Insatsu Kk 磁気カード
DE10329955A1 (de) * 2003-07-03 2005-02-03 Merck Patent Gmbh Verwendung eines hydroalkoholischen Extrakts aus Bauhinia zur Herstellung einer Zubereitung

Also Published As

Publication number Publication date
ES2323082T3 (es) 2009-07-06
CA2571606C (en) 2011-07-19
SI1758555T1 (sl) 2009-08-31
CY1109066T1 (el) 2014-07-02
NZ552280A (en) 2010-10-29
CN1972668A (zh) 2007-05-30
RS50832B (sr) 2010-08-31
JP4468987B2 (ja) 2010-05-26
LTC1758555I2 (lt) 2017-11-10
IL180057A (en) 2013-11-28
AU2005253732A1 (en) 2005-12-29
ES2323082T5 (es) 2012-01-05
KR101162991B1 (ko) 2012-07-10
MXPA06015233A (es) 2007-12-12
AU2005253732B2 (en) 2009-07-16
NL300823I2 (nl) 2017-06-22
RS50832B2 (sr) 2018-09-28
DK1758555T4 (da) 2011-12-19
UA88308C2 (ru) 2009-10-12
EP1758555A1 (de) 2007-03-07
NO20070390L (no) 2007-03-16
FR16C1003I2 (fr) 2018-01-19
KR20070046821A (ko) 2007-05-03
NO2016012I1 (no) 2016-07-07
WO2005123037A1 (de) 2005-12-29
AU2005253732C1 (en) 2010-01-21
FR16C1003I1 (en:Method) 2016-08-26
SI1758555T2 (sl) 2009-08-31
RU2430717C2 (ru) 2011-10-10
US20070299285A1 (en) 2007-12-27
DE502005006701D1 (de) 2009-04-09
DK1758555T3 (da) 2009-06-22
NO2016012I2 (no) 2016-07-07
RU2007102084A (ru) 2008-07-27
ZA200610304B (en) 2007-11-28
US8536380B2 (en) 2013-09-17
CY2016025I1 (el) 2016-10-05
US8828444B2 (en) 2014-09-09
BRPI0512288B8 (pt) 2021-05-25
PT1758555E (pt) 2009-04-24
ATE423546T1 (de) 2009-03-15
BRPI0512288B1 (pt) 2019-05-21
IL180057A0 (en) 2007-05-15
CY2016025I2 (el) 2016-10-05
CA2571606A1 (en) 2005-12-29
US20140050790A1 (en) 2014-02-20
NO336747B1 (no) 2015-10-26
EP1758555B2 (de) 2011-09-07
DE102004030044A1 (de) 2006-01-12
CN1972668B (zh) 2013-01-09
LU93142I2 (fr) 2016-09-06
BRPI0512288A (pt) 2008-03-25
BE2016C035I2 (en:Method) 2024-10-08
LU93142I9 (en:Method) 2024-11-04
HUS1600032I1 (hu) 2016-08-29
PL1758555T3 (pl) 2009-07-31
JP2008503530A (ja) 2008-02-07
EP1758555B1 (de) 2009-02-25

Similar Documents

Publication Publication Date Title
LTC1758555I2 (lt) Oleogelį suformuojantis agentas, turintis triterpeną, triterpeną turintis oleogelis ir triterpeną turinčio oleogelio gavimo būdas
WO2007124092A3 (en) Photoacid generator compounds and compositions
MY150736A (en) Mousse
TW200745759A (en) A chemically amplified positive resist composition
UA98960C2 (uk) Пінні композиції, що не містять поверхнево-активних речовин
FR2913358B1 (fr) Dispositif d'allumage d'une composition aluminothermique, creuset l'incorporant et procedes associes.
NO20083397L (no) Anti-EphB4-antistoffer og fremgangsmater for anvendelse av disse
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
BRPI0702163A (pt) composições de toner e métodos
SG126068A1 (en) Method of increasing the oxidation stability of biodiesel
EA200701029A1 (ru) Новая композиция для облегчения человеческих родов
AR047526A1 (es) Halogenoalquilcarboxamidas
DK1965809T3 (da) Præparater til forbedring af sundhedstilstanden i dyrs tarmsystem og dyrs ydeevne omfattende Beta-glucanerne og Alfa-fucaner
TW200600515A (en) Composition and method for producing same
GB2476628A (en) Method to prevent churn of customers
WO2007146204A3 (en) Methods and apparatus for generating a web site from a use case
琴鍾愛 Development Method of the Discourse in the Shiroishi Dialect
ATE498313T1 (de) Herbizidzusammensetzung
Mizota Impact of Two-way Style Education in 40 years before
Endo Evaluation for the Social Contribution of Engineering Education
UA67056A (en) Method for phytotherapy of immunodeficiency caused by adverse ecological conditions
CU23343A3 (es) Composición de ziprasidona y controles sintéticos
MA31244B1 (fr) Solution solide amorphe contenant un derive de pyrazole-3-carboxamide sous forme amorphe et des excipients stabilisateurs
TR200801449A2 (tr) Entegre alaturka ve alafranga tuvalet uygulaması yöntemi ve bu yöntemi haiz tuvalet
UY29776A1 (es) Nueva asociación entre la agomelatina y un agente timoregulador y composiciones farmacéuticas que la contienen